Traws Pharma, Inc. Property, Plant and Equipment, Gross
Traws Pharma, Inc. (TRAW) had Property, Plant and Equipment, Gross of $84.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-11-14
- 2024-09-30: Property, Plant and Equipment, Gross $84.00K.
- 2024-06-30: Property, Plant and Equipment, Gross $84.00K.
- 2024-03-31: Property, Plant and Equipment, Gross $84.00K.
- 2023-12-31: Property, Plant and Equipment, Gross $84.00K.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2024-09-30 | $84.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $84.00K 10-Q · filed 2024-08-15 |
| 2024-03-31 | $84.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $84.00K 10-Q · filed 2024-11-14 |
| 2023-09-30 | $84.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $70.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $70.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $70.00K 10-Q · filed 2023-11-14 |
| 2022-09-30 | $70.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $70.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $70.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $70.00K 10-Q · filed 2022-11-14 |
| 2021-09-30 | $70.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $70.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $70.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $70.00K 10-Q · filed 2021-11-15 |
| 2020-09-30 | $2.30M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.30M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $2.28M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.28M 10-K · filed 2021-03-18 |
| 2019-09-30 | $2.28M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.23M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.23M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.23M 10-K · filed 2020-03-27 |
| 2018-09-30 | $2.23M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.23M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.23M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.23M 10-K · filed 2019-04-01 |
| 2017-09-30 | $2.23M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.23M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.23M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.23M 10-K · filed 2018-03-16 |
| 2016-09-30 | $2.23M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.23M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $2.23M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $2.23M 10-K · filed 2017-03-29 |
| 2015-09-30 | $2.23M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.55M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $2.62M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.63M 10-K · filed 2016-03-28 |
| 2014-09-30 | $2.62M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $2.62M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $2.47M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $2.40M 10-K · filed 2015-03-30 |
| 2013-09-30 | $2.33M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.28M 10-Q · filed 2013-09-06 |
| 2012-12-31 | $1.81M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |